Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Lee Jackson | Dec 11, 2013 at 9:00 AM EST

Credit Suisse Offers Top Biotech Stocks to Buy for 2014

ThinkstockCredit Suisse is out and pounding the table that biotechnology cannot be ignored in 2014. Biotech has been the top-performing…

Jon C. Ogg | Dec 10, 2013 at 4:04 PM EST

Big Insider Selling at Gilead

ThinkstockGilead Sciences Inc. (NASDAQ: GILD) has been on fire, so much that two insiders decided to stuff their holiday stockings…

Jon C. Ogg | Dec 10, 2013 at 10:10 AM EST

Teva Prospects Keep Dimming, Even If 2014 Sales Drop-Off Limited

ThinkstockTeva Pharmaceutical Industries Ltd. (NYSE: TEVA) has moved from a great growth story to one of promise, to one of…

Jon C. Ogg | Dec 3, 2013 at 11:35 AM EST

Celgene Gets OncoMed Cancer Pipeline, Maybe Dirt Cheap

OncoMed Pharmaceuticals just went from being an obscure biotech to one on the map with more security than it had.…

Douglas A. McIntyre | Nov 24, 2013 at 10:24 AM EST

The Ten Nations With The Worst Air Quality

ThinkstockResearcher find two measurements which best gauge air quality. One comes from object data about the quality itself. The second comes…

Trey Thoelcke | Nov 22, 2013 at 7:00 AM EST

Novartis Announces Share Buybacks and Business Expansion

ThinkstockSpeculation has run hot that Swiss drugmaker Novartis A.G. (NYSE: NVS) would announced further restructuring at its investor day in…

Jon C. Ogg | Nov 21, 2013 at 12:00 PM EST

Time to Sell the Boston Scientific Turnaround?

ThinkstockInvestors have enjoyed a handy recovery in the turnaround of Boston Scientific Corp. (NYSE: BSX). Perhaps that should even say…

Jon C. Ogg | Nov 21, 2013 at 7:25 AM EST

Solid Biotech Stocks With the Best Revenue Growth for 2014

ThinkstockAny time investors look for companies growing sales the most, one area that almost always stands out is the up…

Lee Jackson | Nov 20, 2013 at 8:30 AM EST

Top Oppenheimer Health Care Stocks to Buy for 2014

ThinkstockHealth care has been a top sector for investors this year. The research team at Oppenheimer continues to believe that…

Jon C. Ogg | Nov 19, 2013 at 12:30 PM EST

Horizon Pharma Deal Ramps Up Profitability Timeline

ThinkstockHorizon Pharma Inc. (NASDAQ: HZNP) is having a stellar day after breaking news that it entered into a pact with…

Jon C. Ogg | Nov 19, 2013 at 11:50 AM EST

The $1 Trillion Drug Market Offers Great but Selective Growth in the Next Five Years

ThinkstockThe market for pharmaceuticals and biotech drugs just keeps growing. The so-called patent cliff may be affecting Big Pharma companies…

Jon C. Ogg | Nov 18, 2013 at 2:16 PM EST

Merck Scores in Investigational Melanoma Study Results

ThinkstockSkin cancer treatments remain elusive. While some drugs are on the market for advanced-stage treatment, the most common and longest…

Jon C. Ogg | Nov 14, 2013 at 2:54 PM EST

Did Obamacare Just Start Migrating to Hillarycare?

Healthcare.govCovering the implementation of the Affordable Care Act has been no easy matter and it is a topic that is…

Douglas A. McIntyre | Nov 14, 2013 at 6:40 AM EST

Heath Care Issues Top List of Americans’ Anxieties, Followed by Dysfunctional Government

thinkstockAmerican’s have become sick of the federal health care exchange site. It happened so quickly, as a matter of fact,…

Jon C. Ogg | Nov 13, 2013 at 3:57 PM EST

New Healthcare Enrollment Numbers Continue To Amaze

Healthcare.govThe Affordable Care Act is becoming more and more of a misnomer each day, and its broad appeal is running…

1 … 296 297 298 299 300 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Credit Suisse Offers Top Biotech Stocks to Buy for 2014

Big Insider Selling at Gilead

Teva Prospects Keep Dimming, Even If 2014 Sales Drop-Off Limited

Celgene Gets OncoMed Cancer Pipeline, Maybe Dirt Cheap

The Ten Nations With The Worst Air Quality

Novartis Announces Share Buybacks and Business Expansion

Time to Sell the Boston Scientific Turnaround?

Solid Biotech Stocks With the Best Revenue Growth for 2014

Top Oppenheimer Health Care Stocks to Buy for 2014

Horizon Pharma Deal Ramps Up Profitability Timeline

The $1 Trillion Drug Market Offers Great but Selective Growth in the Next Five Years

Merck Scores in Investigational Melanoma Study Results

Did Obamacare Just Start Migrating to Hillarycare?

Heath Care Issues Top List of Americans’ Anxieties, Followed by Dysfunctional Government

New Healthcare Enrollment Numbers Continue To Amaze

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

Health and Healthcare Articles

All Health and Healthcare Articles

Credit Suisse Offers Top Biotech Stocks to Buy for 2014

Big Insider Selling at Gilead

Teva Prospects Keep Dimming, Even If 2014 Sales Drop-Off Limited

Celgene Gets OncoMed Cancer Pipeline, Maybe Dirt Cheap

The Ten Nations With The Worst Air Quality

Novartis Announces Share Buybacks and Business Expansion

Time to Sell the Boston Scientific Turnaround?

Solid Biotech Stocks With the Best Revenue Growth for 2014

Top Oppenheimer Health Care Stocks to Buy for 2014

Horizon Pharma Deal Ramps Up Profitability Timeline

The $1 Trillion Drug Market Offers Great but Selective Growth in the Next Five Years

Merck Scores in Investigational Melanoma Study Results

Did Obamacare Just Start Migrating to Hillarycare?

Heath Care Issues Top List of Americans’ Anxieties, Followed by Dysfunctional Government

New Healthcare Enrollment Numbers Continue To Amaze

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up